and similar to the CBA/N mouse in their immunological characteristics while female progeny of such crosses are phenotypically normal.
Antigens. Antigens used in these studies included PC-ovalbumin (PC-OVA), PC-mycobacterium H37 Ra (PC-myco), PC-B. abortus (PC-BA) and rough strain pneumococcus (R36A) which bears PC as an immunodominant determinant. Antigens were prepared by the method of Chesebro and Metzger (9) .
Enumeration of Plaque-Forming Cells (PFC) and Anti-PC Antibodies. PFC specific for phosphorylcholine were enumerated by using cII polysaccharide conjugated to sheep erythrocytes (10) . cII contains PC as a predominant antigen. All PFC were inhibitable with concentrations of PC < 10 -4 M. PC antibodies bearing the TEPC 15 idiotype (T15) were determined by hemagglutination inhibition (HI) as previously described (11) .
Cell Culture. Spleen cells were cultured in modified Mishell-Dutton medium containing 10% endotoxin free fetal calf serum and 5 x 10 -s M 2-mercaptoethanol in fiat bottom microtiter trays (Falcon no. 3040 Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) at a density of 10 e cells in 0.2 ml medium per well. Plates were incubated for 3-4 days in a humidified 5% COs, 95% air atmosphere. Cells were collected and IgM PFC were enumerated by a modification of Jerue and Nordin hemolysis in gel assay (12) .
Results and Discussion
Results in Table I show T15 titers in CBA/N x DBA/2N defective F, males and their normal female littermates after immunization with 100 leg of PC-OVA, PC-Myco, or PC°BA or with 106 R36A organisms in complete Freund's adjuvant. F, male mice failed to mount T15 + responses to PC on T-dependent (OVA) or on T-independent (BA, R36A) carriers although these mice can respond to TNP on OVA (13) and on BA.' F~ females developed significant T15 responses as early as 2 wk after immunization with each of these antigens.
As noted above, it has been shown that CBA/N mice and (CBA/N x DBAJ2)F, males and females can respond to certain T-independent antigens including TNP-BA. To directly compare the immunogenicity of PC and of TNP conjugates we studied in vitro primary responses to PC and TNP derivatives ofB. abortus as well as to R36A.
In vitro responses of (CBA/N x BALB/c)F, male and female spleen cells to PC-BA, TNP-BA, and R36A are presented in Table II . F, female cells respond to a wide dose range of dilutions of TNP°BA and of PC-BA. In fact, the antibody responses ofF, female cells to TNP-BA and PC-BA are very comparable at high dilutions of organisms, suggesting that in F, female mice the two antigens have a substantial similarity in immunogenicity. F, male cells are able to mount significant anti-TNP responses to TNpoB. abortus, although over a more narrow range of antigen concentrations than was true of F, female cells. However, F, male cells failed entirely to respond to PC°BA, at all antigen concentrations tested. Similarly, they did not mount an anti-PC response to R36A despite the fact that F, female cells made a significant in vitro response to R36A.
F~ male and female mice were also immunized with PC-BA intravenously and PFC to PC-sheep erythrocytes (SRBC) were determined 4 and 6 days later (Table III) . F~ female mice developed large numbers of direct PFC's which were shown to be PC specific by the capacity of PC to inhibit plaque formation. Preliminary experiments had established that the peak response of normal mice to PC-BA occurred 4-6 days after immunization, and was comparable in magnitude in BALB/c and (CBA/N x DBA/2N)F~ female mice. In sharp contrast to these results, F, male mice formed no measurable anti-PC responses after such immunization. We have recently reported that such immunization with TNP-BA induces TNP-specific PFC in both male and female F1 mice. 1 The inability of these genetically defective mice to mount anti-PC responses in the face of relatively normal ability to develop anti-TNP (13) antibodies as well as antibodies to other specificities including azobenzenearsonate and 3-nitro, 4-hydroxy, 5-bromophenyl acetyl (J. J. Mond, O. M/ikel~i, and W. E. Paul, unpublished observations) when immunized with these determinants conjugated to comparable carriers might be explained by the absence of precursers of anti-PC antibody-forming cells. Indeed, absence of such precursors and of PC-binding cells has been reported to occur in neonatal mice (14) . It is possible that defective mice whose B-cell maturation is arrested or abnormal might never develop lymphocytes expressing this late-appearing receptor. Alternatively, mice with CBA/N X-linked-immune defect may lack an entire lineage of B lymphocytes. This lineage may be responsible for all of the PC response in normal strains either (a) because the expression of V-region genes controlling the T15 idiotype and other PC specificities may be limited to cells of this lineage or (b) because cells of the alternative lineage are tolerized in the neonatal period by contact with PC-bearing environmental antigens. In either case, the CBA/N would lack the line of B cells responsive to PC-antigens in normal mice and thus would fail to respond to PC on any carrier. A final possibility is that CBA/N mice do have PC-binding B cells but that these cells are defective in that they have a high threshold for activation or that they retain the high susceptibility to tolerance induction normally associated with very immature B cells. In any case, it seems most unlikely that the X-linked defect leading to the failure of CBA/N mice to respond to PC can represent the absence of a structural gene for anti-PC antibody since neither H-chain (15) or L-chain (16) genes have been reported to be X-linked.
TAI3LE II

Summary
Mice with the CBA/N defect are unresponsive to the hapten phosphorylcholine (PC) even when presented on a variety ofimmunogenic carriers. Since these mice have the variable region gene for PC, their inability to respond may reflect deletion or suppression of the line of B lymphocytes which is responsible for the anti-PC response.
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